PROGNOSTIC-SIGNIFICANCE OF INTERLEUKIN-6 SERUM LEVELS IN PATIENTS WITH OVARIAN-CANCER

被引:166
作者
SCAMBIA, G
TESTA, U
PANICI, PB
FOTI, E
MARTUCCI, R
GADDUCCI, A
PERILLO, A
FACCHINI, V
PESCHLE, C
MANCUSO, S
机构
[1] UNIV CATTOLICA SACRO CUORE, DEPT OBSTET & GYNECOL, I-00168 ROME, ITALY
[2] IST SUPER SANITA, DEPT HEMATOL & ONCOL, I-00161 ROME, ITALY
[3] UNIV PISA, DEPT OBSTET & GYNECOL, PISA, ITALY
关键词
INTERLEUKIN; 6; CYTOKINES; OVARIAN CANCER; SERUM MARKERS;
D O I
10.1038/bjc.1995.71
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
High levels of IL-6 were found in 50% of 114 patients with primary ovarian cancer. IL-6 sensitivity was lower than that of CA 125, and the combination of both assays did not increase the sensitivity of CA 125 alone. However, elevated IL-6 serum levels were correlated with a poor prognosis since patients with low IL-6 levels had a better survival than patients with high IL-6 levels (P = 0.0009). Multivariate analysis revealed that IL-6 positivity has an independent value.
引用
收藏
页码:354 / 356
页数:3
相关论文
共 20 条
[1]   SERUM INTERLEUKIN-6 LEVELS CORRELATE WITH DISEASE STATUS IN PATIENTS WITH EPITHELIAL OVARIAN-CANCER [J].
BEREK, JS ;
CHUNG, C ;
KALDI, K ;
WATSON, JM ;
KNOX, RM ;
MARTINEZMAZA, O .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1991, 164 (04) :1038-1043
[2]  
BLAY JY, 1992, CANCER RES, V52, P3317
[3]  
DIXON WJ, 1981, BMDP STATISTICAL SOF
[4]  
HONDA M, 1992, J IMMUNOL, V148, P2175
[5]   NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].
KAPLAN, EL ;
MEIER, P .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481
[6]  
MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163
[7]   INTERLEUKIN-6 (IL-6) FUNCTIONS AS AN INVITRO AUTOCRINE GROWTH-FACTOR IN RENAL-CELL CARCINOMAS [J].
MIKI, S ;
IWANO, M ;
MIKI, Y ;
YAMAMOTO, M ;
TANG, B ;
YOKOKAWA, K ;
SONODA, T ;
HIRANO, T ;
KISHIMOTO, T .
FEBS LETTERS, 1989, 250 (02) :607-610
[8]   PATTERN OF INTERLEUKIN-6 GENE-EXPRESSION INVIVO SUGGESTS A ROLE FOR THIS CYTOKINE IN ANGIOGENESIS [J].
MOTRO, B ;
ITIN, A ;
SACHS, L ;
KESHET, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (08) :3092-3096
[9]  
OKADA M, 1988, J IMMUNOL, V141, P1543
[10]   EFFICACY AND TOXICITY OF VERY HIGH-DOSE CISPLATIN IN ADVANCED OVARIAN-CARCINOMA - 4-YEAR SURVIVAL ANALYSIS AND NEUROLOGICAL FOLLOW-UP [J].
PANICI, PB ;
GREGGI, S ;
SCAMBIA, G ;
BAIOCCHI, G ;
LOMONACO, M ;
CONTI, G ;
MANCUSO, S .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1993, 3 (01) :44-53